MORGAN STANLEY

Holdings History for PROKIDNEY CORP. - Ordinary Shares (PROK)

Symbol: PROK on Nasdaq
Investment type: Equity / Ordinary Shares
Latest Disclosed Shares Owned: 5,712,128 shares
Security Ownership %: 4.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in PROKIDNEY CORP. Ordinary Shares (PROK)

07 Aug 2025 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,712,128 shares of PROKIDNEY CORP. Ordinary Shares (PROK). This represents 4.4% ownership of the company. In their previous filing dated 06 May 2025, MORGAN STANLEY had reported owning 10,058,924 shares, indicating a decrease of +43%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Morgan Stanley	4.4%	-42%	$3,370,156	5,712,128	-4,346,796	-43%	$0.59	13G/A	30 Jun 2025	07 Aug 2025, 11:36
Morgan Stanley	7.8%		$10,863,638	10,058,924			$1.08	13G/A	31 Mar 2025	06 May 2025, 15:45

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-5,987,540	-100%	$2.24	Q3 2025
30 Jun 2025		0%	$1	1	0		$1.00 ^*	Q2 2025
30 Jun 2025	0%	-0%	$3,545,222	5,987,540	-4,349,683	-42%	$0.59	Q2 2025
31 Mar 2025	0%	-0%	$9,057,477	10,337,223	-3,636,134		$0.88	Q1 2025
31 Dec 2024	0%	-0%	$23,614,975	13,973,357	-297,028		$1.69	Q4 2024
30 Sep 2024	0%	-0%	$27,399,142	14,270,385	-177,956		$1.92	Q3 2024
30 Jun 2024	0%	+0%	$35,542,922	14,448,341	+4,121,663		$2.46	Q2 2024
31 Mar 2024		0%	$2	1	0		$2.00 ^*	Q1 2024
31 Mar 2024	0%	-0%	$16,935,753	10,326,678	-870,520	-7.8%	$1.64	Q1 2024
31 Dec 2023		0%	$3	1	0		$3.00 ^*	Q4 2023
31 Dec 2023	0%	+0%	$19,931,013	11,197,198	+910,832	+8.9%	$1.78	Q4 2023
30 Sep 2023	0%	+0%	$47,111,560	10,286,366	+590,965	+6.1%	$4.58	Q3 2023
30 Jun 2023		0%	$18	1	0		$18.00 ^*	Q2 2023
30 Jun 2023	0.01%	+0%	$108,491,547	9,695,401	+84,316	+0.88%	$11.19	Q2 2023
31 Mar 2023	0.01%	-0%	$108,797,493	9,611,085	-1,336,410	-12%	$11.32	Q1 2023
31 Dec 2022	0.01%	+0%	$75,099,816	10,947,495	+595,843	+5.8%	$6.86	Q4 2022
30 Sep 2022	0.01%	+0.01%	$93,267,000	10,351,652	+10,351,652	NEW	$9.01	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.